Please login to the form below

Not currently logged in
Email:
Password:

Chlamydia test approved for use in EU

A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use
A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use.

Chlamydia trachomatis is the most commonly diagnosed STI in England, with approximately two-thirds of cases affecting younger age groups. The infection often has no obvious symptoms and left undetected it will not only continue to be spread through the community, but can also lead to complications such as pelvic inflammatory disease or infertility in women.

"Unexpected mutations in the DNA of an infectious agent such as chlamydia can disrupt laboratory testing and, by extension, proper treatment of patients," said Dr Teresa L. Wright, OBE, chief medical officer at Roche Molecular Diagnostics.

This test, known as COBAS TaqMan CT Test v2.0, differs from other tests as it uses a dual target approach helping to ensure reliability even when mutations occur within the bacteria's DNA.

Using specifically designed analysis equipment, results can be obtained just two and a half hours after a sample is prepared.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics